Table 2.
Treatment | New strategies | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Microneedling | FRF | LLLT | Excimer lamp | CO2 laser | PRP | DPC | UC-MSCs | AD-MSCs | BM-MSCs | |
Types | AGA and AA | AGA | AGA | AA | AGA | AGA | PHL | AA | AGA | AA and AGA |
Patients | 50 patients | 25 patients | 110 patients | 105 patients | 45 patients | 25 patients | 65 patients | 3 patients | 3 patients | 40 patients |
Dosage | Microneedling (needle length, 0.5 to 1.5 mm), 15 times a week | Ten treatment sessions at 2-week intervals | For 15 min, thrice a week for 26 weeks | 308-nm excimer lamp | 50-mm tip, 12-18 mJ/spot, 361 spots/cm2 | Once a month for 3 months | 7.1 × 107 autologous DSCs | 1 × 106 cells/mL, twice a month for 12 months |
Cell suspension, injected subcutaneously | 1 × 104 cells/mL, injected intradermally |
Treatment results | Hair shaft thickness↑ | Hair count↑ Hair shaft thickness↑ | Hair density↑ Hair loss↓ |
Hair loss↓ | Hair count↑ Hair thickness↑ |
Hair density↑ | Hair density↑ | Hair regrowth↑ | Wounds↓ Hair regrowth↑ |
Hair regrowth↑ |
Adverse effects | Pain, bruising, and discomfort at site | Scalp pain and slight burning sensation | Scalp tenderness, paresthesia, and mild urticaria | Scalp pain and slight burning sensation | Scalp tenderness and paresthesia | Scalp pain and pinpoint | Scalp pain and pinpoint | Scalp pain and pinpoint | Scalp pain and pinpoint | Scalp pain and pinpoint |
References | 74 | 77 | 82 | 86 | 150 | 97 | 108 | 122 | 127 | 130 |